<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04255628</url>
  </required_header>
  <id_info>
    <org_study_id>201911071RINC</org_study_id>
    <nct_id>NCT04255628</nct_id>
  </id_info>
  <brief_title>The Brain Metabolic Change in Chronic Cancer Pain Patient: FDG PET Image Study</brief_title>
  <official_title>The Brain Metabolic Change in Chronic Cancer Pain Patient: FDG PET Image Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cancer pain deteriorated in quality of life and related with numerous psychosocial problems.&#xD;
      Over the one third of cancer patient suffered from moderate to severe cancer pain, even under&#xD;
      adequate pain management.&#xD;
&#xD;
      The 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT)&#xD;
      images can provide quantitative results in clinical oncology. As a functional neuroimaging,&#xD;
      the PET evidently provided anatomical activated regions, size, and spatial extent&#xD;
      information. In this study, we use FDG-PET to investigate changes concerning the glucose&#xD;
      metabolism in the brain with or without cancer pain. Therefore, we may provide useful&#xD;
      information to treatment target in cancer pain patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overall, cancer incidence has decreased and the rate of cancer deaths in both men and women&#xD;
      has also significantly declined among both men and women in all site.However, the prevalence&#xD;
      of chronic pain is 28.2%, ranging from 22.5% to 35.4%, depending on the location of the&#xD;
      primary tumor, and neuropathic characteristics were observed in 19.9% of patients with&#xD;
      chronic cancer pain.&#xD;
&#xD;
      Despite numerous studies on cancer pathogenesis and diagnosis, few reports have demonstrated&#xD;
      the brain mechanism underlying cancer pain. One study used resting functional magnetic&#xD;
      resonance imaging (fMRI) to identify the changes in the functional brain network of chronic&#xD;
      bone cancer pain mice under anesthesia. Cancer-induced bone pain (CIBP) might alter resting&#xD;
      state activity of the cingulate cortex, prefrontal cortex (PFC) and ventral striatum,&#xD;
      indicating a strong affective component of the CIBP mice.In imaging studies of human patients&#xD;
      with cancer, patients with chronic cancer pain exhibited activation in the PFC.&#xD;
&#xD;
      The 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT)&#xD;
      images can provide quantitative results in clinical oncology.Owing to the higher glucose&#xD;
      metabolic rate in the brain, brain FDG-PET images are not routinely used in the clinical&#xD;
      setting. However, several studies have demonstrated functional brain changes in human pain&#xD;
      condition.In this study, we use FDG-PET to investigate changes concerning the glucose&#xD;
      metabolism in the brain with or without cancer pain.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Brain metabolism change</measure>
    <time_frame>12 months</time_frame>
    <description>The FDG-PET of Standardized uptake values (SUVs) were calculated for each voxel in the reconstructed images to investigate changes concerning the glucose metabolism in the brain with or without cancer pain</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cancer Pain</condition>
  <arm_group>
    <arm_group_label>with cancer pain</arm_group_label>
    <description>head and neck and esophageal cancer patients. with cancer pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without cancer pain</arm_group_label>
    <description>head and neck and esophageal cancer patients. without cancer pain=30</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>FDG PET</intervention_name>
    <description>Cancer patients who scheduled whole body FDG-PET image scan for clinically indicated.</description>
    <arm_group_label>with cancer pain</arm_group_label>
    <arm_group_label>without cancer pain</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Sixty patients in each group of head and neck and esophageal cancer patients. Each cancer&#xD;
        group include without cancer pain=30, with cancer pain=30.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Cancer patients who scheduled whole body FDG-PET image scan for clinically indicated.&#xD;
&#xD;
          2. Age &gt; 20&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unable to complete questionnaires.&#xD;
&#xD;
          2. Prior evidence of brain metastases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wen-ying Lin</last_name>
    <phone>+886972652006</phone>
    <email>ying434@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hosipital</name>
      <address>
        <city>Taipei City</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen-ying Lin</last_name>
      <phone>0972652006</phone>
      <email>ying434@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>February 3, 2020</study_first_submitted>
  <study_first_submitted_qc>February 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>September 5, 2021</last_update_submitted>
  <last_update_submitted_qc>September 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

